VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is the first to demonstrate the isolation and analysis of >99% pure circulating tumor-derived DNA (ctDNA).
Move beyond one-size-fits-all. Discover a six-step, employee-driven approach to implementing PPE programs that actually protect women in the workforce.
GOTHENBURG, Sweden, March 18, 2026 - Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) today announces that the company has expanded its global exclusive license agreement for arfolitixorin to also ...
Universal month-3 NGF MRD negativity (10⁻⁵) followed short-course VRd or daratumumab-based induction and single-infusion YK-hBCMA BB-002, despite high-risk biology and frailty representation. Depth of ...
For oncologists navigating the rapidly evolving landscape of renal cell carcinoma (RCC), the data presented at the 2026 ASCO ...
Targets $36 Billion TAM in Early Cancer Detection and MRD. Company in active discussions with global diagnostic leaders to accelerate commercialization. HENDERSON, Nev., March 18, ...
ICCA data for 2024 recorded 11,099 international association meetings worldwide, generating USD 11.6 billion in direct ...
When Chadwick Boseman died in August 2020 at the age of 43, the world learned that the beloved star of Black Panther had ...
We would also contend that it’s hard to predict such events a priori(10), and that more normal factor performance – which ...
Background Alcohol use disorder and treatment-resistant depression (TRD) often co-occur, presenting a major clinical challenge with limited effective treatments. However, ketamine produces rapid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results